| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA3299001
Max Phase: Preclinical
Molecular Formula: C20H26N4O2
Molecular Weight: 354.45
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CN(C)CCCOc1ccc2nc(O)n(-c3ccc(N(C)C)cc3)c2c1
Standard InChI: InChI=1S/C20H26N4O2/c1-22(2)12-5-13-26-17-10-11-18-19(14-17)24(20(25)21-18)16-8-6-15(7-9-16)23(3)4/h6-11,14H,5,12-13H2,1-4H3,(H,21,25)
Standard InChI Key: WQWBCYHHGIGHTP-UHFFFAOYSA-N
Associated Targets(non-human)
Internal ribosome entry site (IRES) (199 Activities)
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 354.45 | Molecular Weight (Monoisotopic): 354.2056 | AlogP: 3.13 | #Rotatable Bonds: 7 |
| Polar Surface Area: 53.76 | Molecular Species: BASE | HBA: 6 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.00 | CX Basic pKa: 9.23 | CX LogP: 3.55 | CX LogD: 1.69 |
| Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.66 | Np Likeness Score: -1.22 |
References
| 1. Ding K, Wang A, Boerneke MA, Dibrov SM, Hermann T.. (2014) Aryl-substituted aminobenzimidazoles targeting the hepatitis C virus internal ribosome entry site., 24 (14): [PMID:24856063] [10.1016/j.bmcl.2014.05.009] |
Source
Source(1):